Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 2,615.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,695.00
  • 52 Week Low: 2,128.00
  • Currency: UK Pounds
  • Shares Issued: 231.47m
  • Volume: 0
  • Market Cap: £6,053m
  • RiskGrade: 125

Dividend Data

  31-Dec-2031-Dec-1931-Dec-1831-Dec-1731-Dec-16
Interim Dividend16.00¢14.00¢12.00¢11.00¢11.00¢
Final Dividend34.00¢30.00¢26.00¢23.00¢22.00¢
Total Dividend50.00¢44.00¢38.00¢34.00¢33.00¢
For more dividend details, click here

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
Revenue 2,341.00 2,207.00 2,070.00 1,936.00 1,950.00
Operating Profit/(Loss) 579.00 493.00 371.00 (747.00) 302.00
Net Interest (22.00) n/a (77.00) 9.00 (92.00)
Profit Before Tax 558.00 491.00 293.00 (738.00) 210.00
Profit After Tax 430.00 487.00 285.00 (839.00) 158.00
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 430.00 487.00 285.00 (839.00) 158.00
Attributable to:          
Equity Holders of Parent Company 431.00 486.00 282.00 (843.00) 155.00
Minority Interests (1.00) 1.00 3.00 4.00 3.00
           
Continuing EPS          
Earnings per Share - Basic 182.60¢ 200.80¢ 117.00¢ (351.30¢) 66.50¢
Earnings per Share - Diluted 181.10¢ 200.00¢ 116.50¢ (349.80¢) 66.20¢
Earnings per Share - Adjusted 172.90¢ 150.40¢ 137.80¢ 105.00¢ 118.50¢
Continuing and Discontinued EPS          
Earnings per Share - Basic 182.60¢ 200.80¢ 117.00¢ (351.30¢) 66.50¢
Earnings per Share - Diluted 181.10¢ 200.00¢ 116.50¢ (349.80¢) 66.20¢
Earnings per Share - Adjusted 172.90¢ 150.40¢ 137.80¢ 105.00¢ 118.50¢
           
Dividend per Share 50.00¢ 44.00¢ 38.00¢ 34.00¢ 33.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Assets          
Non-Current Assets          
Property, Plant & Equipment 1,068.00 962.00 870.00 828.00 969.00
Intangible Assets 876.00 834.00 766.00 785.00 1,719.00
Investment Properties n/a n/a n/a n/a n/a
Investments 9.00 11.00 11.00 6.00 7.00
Other Financial Assets n/a n/a 57.00 60.00 48.00
Other Non-Current Assets 260.00 275.00 125.00 135.00 172.00
  2,213.00 2,082.00 1,829.00 1,814.00 2,915.00
Current Assets          
Inventories 757.00 568.00 528.00 488.00 459.00
Trade & Other Receivables 756.00 719.00 805.00 760.00 761.00
Cash at Bank & in Hand 323.00 442.00 276.00 227.00 155.00
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 86.00 119.00 59.00 99.00 73.00
  1,922.00 1,848.00 1,668.00 1,574.00 1,448.00
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 4,135.00 3,930.00 3,497.00 3,388.00 4,363.00
           
Liabilities          
Current Liabilities          
Borrowings 168.00 578.00 75.00 86.00 117.00
Other Current Liabilities 860.00 893.00 818.00 711.00 801.00
  1,028.00 1,471.00 893.00 797.00 918.00
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 764.00 107.00 562.00 690.00 742.00
Provisions 31.00 20.00 16.00 49.00 15.00
Other Non-Current Liabilities 164.00 203.00 329.00 324.00 277.00
  959.00 330.00 907.00 1,063.00 1,034.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 1,987.00 1,801.00 1,800.00 1,860.00 1,952.00
           
Net Assets 2,148.00 2,129.00 1,697.00 1,528.00 2,411.00
           
Capital & Reserves          
Share Capital 41.00 41.00 40.00 40.00 40.00
Share Premium Account 282.00 282.00 282.00 282.00 282.00
Other Reserves (80.00) (179.00) (217.00) (190.00) 2,074.00
Retained Earnings 1,892.00 1,973.00 1,580.00 1,382.00 n/a
Shareholders Funds 2,135.00 2,117.00 1,685.00 1,514.00 2,396.00
           
Minority Interests/Other Equity 13.00 12.00 12.00 14.00 15.00
Total Equity 2,148.00 2,129.00 1,697.00 1,528.00 2,411.00
Cash Flow 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Net Cash Flow From Operating Activities 464.00 472.00 430.00 443.00 293.00
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (283.00) (151.00) (96.00) (151.00) (695.00)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (298.00) (155.00) (278.00) (220.00) 19.00
Net Increase/Decrease In Cash (117.00) 166.00 56.00 72.00 (383.00)
Ratios - based on IFRS 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
PE Ratio - Adjusted 20.2 18.4 17.3 15.0 22.2
PEG - Adjusted 1.3 2.0 0.6 n/a n/a
Earnings per Share Growth - Adjusted 15% 9% 31% -11% -18%
Dividend Cover 3.46 3.42 3.63 3.09 3.59
Revenue per Share 991.95¢ 911.98¢ 858.92¢ 836.38¢ 836.91¢
Pre-Tax Profit per Share 236.44¢ 202.89¢ 121.58¢ (318.83¢) 90.13¢
Operating Margin 24.73% 22.34% 17.92% (38.58%) 15.49%
Return on Capital Employed 25.95% 24.55% 23.36% n/a 19.28%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 20.2 18.4 17.3 15.0 22.2
PEG - Adjusted 1.3 2.0 0.6 n/a n/a
Earnings per Share Growth - Adjusted 15% 9% 31% -11% -18%
Dividend Cover 3.46 3.42 3.63 3.09 3.59
           
Dividend Yield 1.4% 1.6% 1.6% 2.2% 1.3%
Dividend per Share Growth 13.64% 15.79% 11.76% 3.03% 3.13%
Operating Cash Flow per Share 196.61¢ 195.04¢ 178.42¢ 191.38¢ 125.75¢
Cash Incr/Decr per Share (49.58¢) 68.59¢ 23.24¢ 31.11¢ (164.38¢)
Net Asset Value per Share (exc. Intangibles) 538.98¢ 535.12¢ 386.31¢ 320.99¢ 297.00¢
Net Gearing 28.52% 11.48% 21.42% 36.26% 29.38%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page